Study validates disc diffusion test for Salmonella vaccine strains

A newly published paper in Veterinary Sciences says a disc diffusion method can reliably differentiate a bivalent live Salmonella vaccine from field strains of Salmonella Enteritidis and Salmonella Typhimurium, based on validation across multiple suppliers. That may sound technical, but it speaks to a very practical challenge in poultry health: when a flock tests positive for Salmonella, veterinarians and diagnostic labs need to know quickly whether they’re seeing a vaccine strain or a strain with regulatory and food safety implications. (pmc.ncbi.nlm.nih.gov)

The backdrop is a long-running EU effort to reduce zoonotic Salmonella in poultry, especially the serovars most associated with human illness. European control programs continue to target S. Enteritidis and S. Typhimurium, and vaccination has been one of the tools used to push prevalence down in breeding and laying flocks. At the same time, those programs create pressure for accurate differentiation, because a recovered vaccine strain should not be interpreted the same way as a true field isolate. EU guidance and technical materials explicitly note that vaccine strains need stable markers that distinguish them from wild-type strains, and that reporting frameworks treat relevant vaccine strains differently from field strains. (food.ec.europa.eu)

That’s where this study fits. Existing DIVA-style approaches already include PCR assays designed to distinguish commercial vaccine strains from wild-type isolates, including MDPI-published work on RT-PCR methods for AviPro Salmonella VAC E and VAC T strains. But PCR-based methods can require specific equipment, assay design, and validation capacity that may not be available in every routine lab. By validating a disc diffusion approach across multiple suppliers, the new paper appears aimed at a more accessible workflow that can slot into standard bacteriology practice. (mdpi.com)

The broader industry context supports that need. EURL Salmonella materials describe antimicrobial susceptibility testing as part of DIVA testing for live vaccine strains, and prior literature has highlighted the operational consequences of failing to distinguish vaccine from field isolates, including unnecessary market disruption or even culling decisions. Other recent research has moved in parallel toward PCR and genomic methods for the same reason: vaccine-origin strains can persist in poultry systems and show up during routine surveillance, making interpretation more complicated than a simple positive-or-negative result. (eurlsalmonella.eu)

Direct outside commentary on this specific paper was limited in the material available through web search, but the surrounding literature and technical presentations point to the same message: differentiation is no longer a niche laboratory issue. It’s part of how vaccination, surveillance, and food safety regulation have to work together. Industry-facing materials have also framed vaccine-strain differentiation as essential to monitoring salmonellosis in poultry, especially in markets where laying-hen and breeder programs are tightly regulated. (en.engormix.com)

Why it matters: For poultry veterinarians, diagnosticians, and food animal health teams, the value here is operational. A reliable, lower-complexity differentiation method could shorten the time between isolation and interpretation, support more confident conversations with regulators and integrators, and help avoid unnecessary interventions when a vaccine strain is the source of a positive result. That matters as Salmonella remains a major zoonotic concern in Europe, with recent EU One Health reporting showing continued pressure in poultry surveillance and ongoing relevance of Enteritidis and Typhimurium in laying hens and human disease. (efsa.europa.eu)

What to watch: The next question is whether diagnostic networks and poultry health programs treat this disc diffusion method as a stand-alone screening tool, or as a front-end test followed by PCR confirmation in ambiguous cases. It’s also worth watching whether regulators, reference labs, or vaccine manufacturers incorporate the approach into formal guidance, especially as surveillance systems continue to balance widespread live vaccination with the need for precise, defensible reporting. (mdpi.com)